This page shows Beneficient-A (BENF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Beneficient-A passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Beneficient-A generates $46.95 in operating cash flow (-$37.7M OCF vs -$803K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Beneficient-A earns $-1.6 in operating income for every $1 of interest expense (-$24.2M vs $14.9M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Beneficient-A's EBITDA was -$22.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 99.1% from the prior year.
Beneficient-A reported -$803K in net income in fiscal year 2025. This represents an increase of 100.0% from the prior year.
Cash & Balance Sheet
Beneficient-A generated -$38.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 35.3% from the prior year.
Beneficient-A held $1.3M in cash against $0 in long-term debt as of fiscal year 2025.
Margins & Returns
Capital Allocation
Beneficient-A invested $1.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 37.5% from the prior year.
BENF Income Statement
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19K-99.9% | $18.7M+186600.0% | $10K0.0% | $10K | N/A | $4.4M-48.4% | $8.6M-14.8% | $10.0M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $4K-99.9% | $3.9M+122.1% | -$17.9M+80.7% | -$92.6M | N/A | -$9.5M+30.6% | -$13.7M-130.9% | $44.3M |
| Interest Expense | $4K-99.9% | $5.8M+18.6% | $4.9M+43.4% | $3.4M | N/A | $3.2M-25.0% | $4.3M+0.7% | $4.3M |
| Income Tax | $713 | $0-100.0% | $43K | $0 | N/A | $713K | $0-100.0% | $28K |
| Net Income | $20K-99.9% | $19.9M+211.2% | -$17.9M+80.7% | -$92.6M | N/A | -$8.6M-188.6% | $9.7M-78.0% | $44.3M |
| EPS (Diluted) | $0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BENF Balance Sheet
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $338K-99.9% | $337.9M+6.8% | $316.2M-5.5% | $334.5M-5.7% | $354.9M-11.3% | $400.0M+8.5% | $368.8M+2.1% | $361.3M |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $8K-99.9% | $7.9M+60.5% | $4.9M-35.6% | $7.6M+465.5% | $1.3M-67.6% | $4.1M-7.4% | $4.5M+1.9% | $4.4M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $10K-99.9% | $9.9M0.0% | $9.9M0.0% | $9.9M0.0% | $9.9M0.0% | $9.9M0.0% | $9.9M-2.9% | $10.2M |
| Total Liabilities | $209K-100.0% | $466.4M+1.6% | $459.1M+0.9% | $454.9M+16.7% | $389.8M+1.0% | $385.8M+1.0% | $382.0M-25.0% | $509.6M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | $100K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $129K+100.1% | -$128.6M+10.0% | -$142.8M-18.6% | -$120.4M-244.7% | -$34.9M-344.9% | $14.3M+208.1% | -$13.2M+91.1% | -$148.3M |
| Retained Earnings | $2.1M+100.1% | -$2.1B+1.0% | -$2.1B-0.2% | -$2.1B-3.2% | -$2.0B0.0% | -$2.0B-0.4% | -$2.0B+0.6% | -$2.0B |
BENF Cash Flow Statement
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $35K+100.4% | -$9.4M+35.5% | -$14.5M-34.1% | -$10.8M | N/A | -$10.0M-16.1% | -$8.6M+19.1% | -$10.6M |
| Capital Expenditures | $96 | $0 | $0-100.0% | $96K | N/A | $42K-84.4% | $269K-59.5% | $664K |
| Free Cash Flow | $35K+100.4% | -$9.4M+35.5% | -$14.5M-32.9% | -$10.9M | N/A | -$10.0M-13.1% | -$8.9M+21.5% | -$11.3M |
| Investing Cash Flow | $59K-99.6% | $16.4M+0.3% | $16.4M-38.1% | $26.5M | N/A | $6.2M+30.4% | $4.8M-25.3% | $6.4M |
| Financing Cash Flow | $18K+100.4% | -$4.1M+10.3% | -$4.6M+51.3% | -$9.4M | N/A | $3.2M-18.9% | $3.9M+295.9% | $991K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BENF Financial Ratios
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 21.1%0.0pp | 21.1%+178661.1pp | -178640.0%+747840.0pp | -926480.0% | N/A | -215.3%-55.1pp | -160.2%-601.6pp | 441.4% |
| Net Margin | 106.7%0.0pp | 106.7%+179176.7pp | -179070.0%+747410.0pp | -926480.0% | N/A | -195.5%-309.4pp | 113.9%-327.2pp | 441.1% |
| Return on Equity | 15.5% | N/A | N/A | N/A | N/A | -60.6% | N/A | N/A |
| Return on Assets | 5.9%0.0pp | 5.9%+11.5pp | -5.7%+22.0pp | -27.7% | N/A | -2.2%-4.8pp | 2.6%-9.6pp | 12.3% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.78+4.4 | -3.63-0.4 | -3.21+0.6 | -3.78+7.4 | -11.16-38.2 | 27.05+56.0 | -28.96-25.5 | -3.44 |
| FCF Margin | 185.5%+235.7pp | -50.2%+145229.8pp | -145280.0%-35960.0pp | -109320.0% | N/A | -227.2%-123.5pp | -103.7%+8.8pp | -112.6% |
Note: Shareholder equity is negative (-$34.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Frequently Asked Questions
Is Beneficient-A profitable?
No, Beneficient-A (BENF) reported a net income of -$803K in fiscal year 2025.
What is Beneficient-A's EBITDA?
Beneficient-A (BENF) had EBITDA of -$22.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Beneficient-A's free cash flow?
Beneficient-A (BENF) generated -$38.8M in free cash flow during fiscal year 2025. This represents a 35.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Beneficient-A's operating cash flow?
Beneficient-A (BENF) generated -$37.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Beneficient-A's total assets?
Beneficient-A (BENF) had $354.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Beneficient-A's capital expenditures?
Beneficient-A (BENF) invested $1.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Beneficient-A's debt-to-equity ratio?
Beneficient-A (BENF) had a debt-to-equity ratio of -11.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Beneficient-A's return on assets (ROA)?
Beneficient-A (BENF) had a return on assets of -0.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Beneficient-A's cash runway?
Based on fiscal year 2025 data, Beneficient-A (BENF) had $1.3M in cash against an annual operating cash burn of $37.7M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Beneficient-A's debt-to-equity ratio negative or unusual?
Beneficient-A (BENF) has negative shareholder equity of -$34.9M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Beneficient-A's Piotroski F-Score?
Beneficient-A (BENF) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Beneficient-A's earnings high quality?
Beneficient-A (BENF) has an earnings quality ratio of 46.95x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Beneficient-A cover its interest payments?
Beneficient-A (BENF) has an interest coverage ratio of -1.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.